Trial · NCT06474286
Prucalopride for Cognitive Functioning in Schizophrenia
NCT06474286, Not applicable, Not yet recruiting, University of Pittsburgh
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prucalopride for Cognitive Functioning in Schizophrenia. Trials, record NCT06474286. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06474286
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prucalopride for Cognitive Functioning in Schizophrenia
- NCT number
- NCT06474286
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 34 participants, estimated
- Lead sponsor
- University of Pittsburgh
- Conditions
- Schizophrenia
- Interventions
- Prucalopride 1 MG
- First posted
- 2024-06-25
- Last updated
- 2026-09-17
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Positive and Negative Syndrome Scale for Schizophrenia (PANSS )Score | PANSS scores measured at baseline and at the end of 4 weeks | There will be change is PANSS score at the end of the study. The score is to assess symptoms. Lowest score is 30 and highest is 210. |
| Primary | Cognitive Functioning (List learning) | Baseline and and at the end of 4 weeks | To study the change in the cognitive functioning as measured by list learning after intervention. Scores range between 0 and 30. |
| Primary | Cognitive Functioning (Digit sequencing task) | Baseline and and at the end of 4 weeks | To study the change in the cognitive functioning as measured by Digit sequencing task after intervention, It ranges from 0 to 28 points |
| Primary | Cognitive Functioning (Token motor task) | Baseline and and at the end of 4 weeks | To study the change in the cognitive functioning as measured by Token motor task after intervention. It ranges from 0 to 100 points, |
| Primary | Cognitive Functioning (Tower test) | Baseline and and at the end of 4 weeks | To study the change in the cognitive functioning as measured by Tower test after intervention |
| Primary | Cognitive Functioning (Symbol coding) | Baseline and and at the end of 4 weeks | To study the change in the cognitive functioning as measured by Symbol coding after intervention. It ranges from 0 to 22 points. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| D43TW009114 | Psychiatric research infrastructure for intervention and implementation in India – TEAMS | NIMGAONKAR, VISHWAJIT LAXMIKANT; HAWK, MARY ELIZABETH | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | FOGARTY INTERNATIONAL CENTER | 2014 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06474286
GET https://conductscience.org/api/trials/v1/NCT06474286/registered